Clinical Pharmacokinetics of Retigabine/Ezogabine

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|8|4|319-331

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.8, Iss.4, 2013-11, pp. : 319-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retigabine/Ezogabine, a KCNQ/KV7 channel opener: pharmacological and clinical data

By Orhan Gökce   Wuttke Thomas V   Nies Anne T   Schwab Matthias   Lerche Holger  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1807-1816

Informa Healthcare

Access to resources Recommend Favorite

Effect of Hemodialysis on Pharmacokinetics of Ezogabine/Retigabine and its N-Acetyl Metabolite in Patients with End Stage Renal Disease

By  

Current Clinical Pharmacology, Vol. 9, Iss. 4, 2014-11 ,pp. : 319-325

Bentham Science Publishers

Access to resources Recommend Favorite

Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with Epilepsy

By Deeks Emma D.  

CNS Drugs, Vol. 25, Iss. 10, 2011-10 ,pp. : 887-900

Adis International

Access to resources Recommend Favorite

The Interaction Potential of Retigabine (Ezogabine) with Other Antiepileptic Drugs

By  

Current Clinical Pharmacology, Vol. 9, Iss. 2, 2014-05 ,pp. : 148-156

Bentham Science Publishers

Access to resources Recommend Favorite

Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel

By Faulkner Michele A   Burke Rachel A  

Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. : 847-855

Informa Healthcare

Access to resources Recommend Favorite